What You Should Know: – OM1, the leader in real-world insights synthesis and evidence generation for life sciences supporting population and personalized data insights, evidence generation through advanced validated AI platforms, big deep clinical…
Continue Reading
What You Should Know: – TRIPP, a wellness technology company, announced the launch of Kōkua XR, an AI-powered meditation guide available in virtual reality. – Building on the success of its mobile version, Kōkua…
Continue Reading
What You Should Know:
– b.well Connected Health, the company powering platform-enabled healthcare ecosystems, announced today it has launched configurable artificial intelligence (AI) architecture integrated directly into its FHIR-based platform.
– Backed by the richest longitudinal dataset…
Continue Reading
What You Should Know: – Jaan Health, a provider of chronic care management and proactive care, announced a partnership with NeuroNet, a national organization representing over 1,000 providers from 80 leading neurology practices. –…
Continue Reading
OMNY Health, which helps hospitals monetize operational data, has launched an AI-powered platform for health technology companies to leverage its data on over 75 million patients. The first two companies to utilize the data are…
Continue Reading
The Office of the National Coordinator for Health IT seeks input on terminology standards and value sets for maternal health information exchange by July 31, 2024. The agency has framed questions to help guide…
Continue Reading
Peter White, chief nursing information officer at Alder Hey Children’s Hospital Trust tells Digital Health News about an ongoing project to create a standardised pediatric dataset for infusion pumps.The trust aims go live with…
Continue Reading
What You Should Know:
– Helix, a leader in population genomics, is launching new datasets designed to empower life science companies in developing precision medicine therapies.
– These comprehensive datasets, built through collaborations with various health…
Continue Reading
Molecular classification, particularly microsatellite instability-high (MSI-H), has gained attention for immunotherapy in endometrial cancer (EC). MSI-H is associated with DNA mismatch repair defects and is a crucial treatment predictor. The NCCN guidelines recommend pembrolizumab…
Continue Reading
The coronary angiogram is the gold standard for evaluating the severity of coronary artery disease stenoses. Presently, the assessment is conducted visually by cardiologists, a method that lacks standardization. This study introduces DeepCoro, a…
Continue Reading
